Product Recalls in Washington

Product recalls affecting Washington — including food, drugs, consumer products, medical devices, and vehicles distributed to Washington. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,840 recalls have been distributed to Washington in the last 12 months.

51,768 total recalls
2,840 in last 12 months

Showing 10411060 of 13,410 recalls

DrugMay 17, 2024· Breckenridge Pharmaceutical, Inc

Recalled Item: Duloxetine Delayed-Release Capsules Recalled by Breckenridge Pharmaceutical,...

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 17, 2024· GlaxoSmithKline LLC

Recalled Item: Tivicay PD (dolutegravir) 5mg Tablets for Oral Suspension Recalled by...

The Issue: Labeling: Incorrect Lot and/or Expiration Date: The carton has incorrect...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMay 16, 2024· Zydus Pharmaceuticals (USA) Inc

Recalled Item: Estradiol Transdermal System Recalled by Zydus Pharmaceuticals (USA) Inc Due...

The Issue: Failed Impurities/Degradation Specifications.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMay 16, 2024· Zydus Pharmaceuticals (USA) Inc

Recalled Item: Estradiol Transdermal System Recalled by Zydus Pharmaceuticals (USA) Inc Due...

The Issue: Failed Impurities/Degradation Specifications.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMay 16, 2024· Rising Pharma Holding, Inc.

Recalled Item: Pregabalin Capsules 50mg Recalled by Rising Pharma Holding, Inc. Due to...

The Issue: Presence of Foreign Tablets/Capsules: Complaint received from a re-packager,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMay 15, 2024· Regeneron Pharmaceuticals Inc

Recalled Item: EYLEA Recalled by Regeneron Pharmaceuticals Inc Due to Lack of Assurance of...

The Issue: Lack of Assurance of Sterility: Complaints of syringe breakage

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 14, 2024· Imprimis NJOF, LLC

Recalled Item: Prednisolone-Moxifloxacin-Bromfenac Sterile Ophthalmic Suspension Recalled...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 14, 2024· Imprimis NJOF, LLC

Recalled Item: Moxifloxacin 4 mg/0.8 mL Preservative-Free 0.8mL Single-Use vials for...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 14, 2024· Imprimis NJOF, LLC

Recalled Item: Klarity-C (cyclosporine) Preservative-Free Sterile Ophthalmic Emulsion 0.1%...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 14, 2024· Imprimis NJOF, LLC

Recalled Item: Dexamethasone-Moxifloxacin- Ketorolac (1mg/mL Recalled by Imprimis NJOF, LLC...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 14, 2024· Imprimis NJOF, LLC

Recalled Item: Moxifloxacin 0.8 mg/0.8 mL Preservative-Free 0.8mL Single-Use vials for...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 14, 2024· Imprimis NJOF, LLC

Recalled Item: Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free 1mL...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 14, 2024· Imprimis NJOF, LLC

Recalled Item: Dexamethasone-Moxifloxacin (1 mg/mL and 5mg/mL) Preservative-Free Recalled...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 14, 2024· Imprimis NJOF, LLC

Recalled Item: Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free 1mL...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 13, 2024· Golden State Medical Supply Inc.

Recalled Item: Duloxetine Delayed-Release Capsules Recalled by Golden State Medical Supply...

The Issue: CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 13, 2024· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Rizatriptan Benzoate Orally Disintegrating Tablets Recalled by Glenmark...

The Issue: CGMP Deviations: N-Nitroso Desmethyl Rizatriptan Impurity results that are...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 13, 2024· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Rizatriptan Benzoate Orally Disintegrating Tablets Recalled by Glenmark...

The Issue: CGMP Deviations: N-Nitroso Desmethyl Rizatriptan Impurity results that are...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 13, 2024· American Regent, Inc.

Recalled Item: Vasopressin Injection Recalled by American Regent, Inc. Due to Subpotent...

The Issue: Subpotent product in addition to having out-of-specification results for...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 10, 2024· Bryant Ranch Prepack, Inc.

Recalled Item: Cephalexin for Oral Suspension Recalled by Bryant Ranch Prepack, Inc. Due to...

The Issue: Labeling: Not Elsewhere Classified: Back Label states 'Each contains:...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMay 10, 2024· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Rizatriptan Benzoate Tablets USP Recalled by Glenmark Pharmaceuticals Inc.,...

The Issue: CGMP Deviations: N-Nitroso Desmethyl Rizatriptan Impurity results that are...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund